Cargando…
Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity
In recent years, immunotherapy has become a powerful therapeutic option against multiple malignancies. The unique capacity of natural killer (NK) cells to attack cancer cells without antigen specificity makes them an optimal immunotherapeutic tool for targeting tumors. Several approaches are current...
Autores principales: | Mendoza-Valderrey, Alberto, Alvarez, Maite, De Maria, Andrea, Margolin, Kim, Melero, Ignacio, Ascierto, Maria Libera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562848/ https://www.ncbi.nlm.nih.gov/pubmed/36231109 http://dx.doi.org/10.3390/cells11193147 |
Ejemplares similares
-
Bringing the Next Generation of Immuno-Oncology Biomarkers to the Clinic
por: Cesano, Alessandra, et al.
Publicado: (2018) -
Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy
por: Ascierto, Maria Libera, et al.
Publicado: (2015) -
Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
por: Pan, Chongxian, et al.
Publicado: (2020) -
Next-generation ctDNA-driven clinical trials in precision immuno-oncology
por: Aggarwal, Charu, et al.
Publicado: (2023) -
Next generation mouse models of squamous cell lung cancer for translational immuno-oncology
por: Hai, Josephine
Publicado: (2020)